Sandy Faulkner, R.N. (Director, Clinical Development) has over 15 years of pharmaceutical industry experience in clinical development and medical affairs (Phase I-IV) with extensive experience in the development of novel endocrinology related products. She has developed clinical and regulatory strategy, protocols, budgets, and timelines, prepared regulatory filings, and supported marketing objectives for increased product usage. She was responsible for the clinical project management of all clinical studies included in the NDA for AndroGel®. These reports and associated summaries were completed in–house, submitted on schedule, and the NDA was approved after only a ten-month review by FDA. Prior to entering the pharmaceutical field, Ms. Faulkner practiced nursing.

email: sfaulkner@clarustherapeutics.com

<< Back